Operating Margin of Bolt Biotherapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary: Bolt Biotherapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
Bolt Biotherapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -884%, a 14% decline year-over-year.
Bolt Biotherapeutics, Inc. annual Operating Margin for 2024 was -950%, a 1.8% increase from 2023.
Bolt Biotherapeutics, Inc. annual Operating Margin for 2023 was -967%, a 39% increase from 2022.
Bolt Biotherapeutics, Inc. annual Operating Margin for 2022 was -1577%, a 79% increase from 2021.

Operating Margin, Quarterly (%)

Operating Margin, YoY Quarterly Change (%)

Operating Margin, Annual (%)

Operating Margin, YoY Annual Change (%)

Bolt Biotherapeutics, Inc. Quarterly Operating Margin (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2025	-884%	-108%	-14%	01 Jul 2025	30 Sep 2025
Q2 2025	-1312%	-617%	-89%	01 Apr 2025	30 Jun 2025
Q1 2025	-1871%	-1210%	-183%	01 Jan 2025	31 Mar 2025
Q4 2024	-950%	+18%	+1.8%	01 Oct 2024	31 Dec 2024
Q3 2024	-776%	+300%	+28%	01 Jul 2024	30 Sep 2024
Q2 2024	-695%	+508%	+42%	01 Apr 2024	30 Jun 2024
Q1 2024	-661%	+597%	+47%	01 Jan 2024	31 Mar 2024
Q4 2023	-967%	+609%	+39%	01 Oct 2023	31 Dec 2023
Q3 2023	-1076%			01 Jul 2023	30 Sep 2023
Q2 2023	-1204%			01 Apr 2023	30 Jun 2023
Q1 2023	-1259%			01 Jan 2023	31 Mar 2023
Q4 2022	-1577%			01 Oct 2022	31 Dec 2022

Period	Value	YoY Chg	Change %	Start Date	End Date
2024	-950%	+18%	+1.8%	01 Jan 2024	31 Dec 2024
2023	-967%	+609%	+39%	01 Jan 2023	31 Dec 2023
2022	-1577%	+5788%	+79%	01 Jan 2022	31 Dec 2022
2021	-7364%	+13927%	+65%	01 Jan 2021	31 Dec 2021
2020	-21291%			01 Jan 2020	31 Dec 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.